Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Rb targets histone H3 methylation and HP1 to promoters.

Nature | Aug 2, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11484059

In eukaryotic cells the histone methylase SUV39H1 and the methyl-lysine binding protein HP1 functionally interact to repress transcription at heterochromatic sites. Lysine 9 of histone H3 is methylated by SUV39H1 (ref. 2), creating a binding site for the chromo domain of HP1 (refs 3, 4). Here we show that SUV39H1 and HP1 are both involved in the repressive functions of the retinoblastoma (Rb) protein. Rb associates with SUV39H1 and HP1 in vivo by means of its pocket domain. SUV39H1 cooperates with Rb to repress the cyclin E promoter, and in fibroblasts that are disrupted for SUV39, the activity of the cyclin E and cyclin A2 genes are specifically elevated. Chromatin immunoprecipitations show that Rb is necessary to direct methylation of histone H3, and is necessary for binding of HP1 to the cyclin E promoter. These results indicate that the SUV39H1-HP1 complex is not only involved in heterochromatic silencing but also has a role in repression of euchromatic genes by Rb and perhaps other co-repressor proteins.

Pubmed ID: 11484059 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Cell Line | Chromosomal Proteins, Non-Histone | Cyclin E | Escherichia coli | Female | HeLa Cells | Histone-Lysine N-Methyltransferase | Histones | Humans | Lysine | Methylation | Methyltransferases | Mice | Molecular Sequence Data | Promoter Regions, Genetic | Protein Binding | Protein Methyltransferases | Recombinant Fusion Proteins | Repressor Proteins | Retinoblastoma Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.